Search
Patexia Research
Case number 1:23-cv-00717

Pfizer Inc. et al v. Aurobindo Pharma Limited et al > Documents

Date Field Doc. No.Description (Pages)
Dec 15, 2023 22 SO ORDERED, re 21 Stipulation of Dismissal, filed by PF PRISM IMB B.V., PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc. CASE CLOSED. Signed by Judge Colm F. Connolly on 12/15/2023. (kmd) (Entered: 12/15/2023) (2)
Dec 14, 2023 21 STIPULATION of Dismissal by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 12/14/2023) (2)
Dec 7, 2023 N/A Pro Hac Vice Attorney George J. Barry, III for Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 12/07/2023) (0)
Dec 6, 2023 20 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 12/06/2023) (2)
Dec 6, 2023 N/A SO ORDERED, re 20 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. Ordered by Judge Colm F. Connolly on 12/6/2023. (kmd) (Entered: 12/06/2023) (0)
Oct 17, 2023 18 STIPULATION and [Proposed] Order Staying Case by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 10/17/2023) (2)
Oct 17, 2023 19 SO ORDERED, re 18 STIPULATION and Order Staying Case. ORDER STAYING CASE through and including December 18, 2023 to provide the parties time in which to finalize settlement. Signed by Judge Colm F. Connolly on 10/17/2023. (nmf) (Entered: 10/17/2023) (2)
Oct 17, 2023 N/A Remark: The October 19, 2023 Telephonic Scheduling Conference is canceled as the case is stayed. (nmf) (Entered: 10/17/2023) (0)
Sep 12, 2023 17 Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 10/19/2023 at 08:30 AM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 9/12/2023. (nmf) (Entered: 09/12/2023) (2)
Sep 8, 2023 16 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 09/08/2023) (3)
Sep 8, 2023 N/A SO ORDERED, re 16 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. Ordered by Judge Colm F. Connolly on 9/8/2023. (kmd) (Entered: 09/08/2023) (0)
Sep 8, 2023 N/A Pro Hac Vice Attorneys Timothy H. Kratz and Michael P. Hogan for Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/08/2023) (0)
Aug 31, 2023 14 ANSWER to 1 Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 08/31/2023) (14)
Aug 31, 2023 15 NOTICE OF SERVICE of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery and Pursuant to the Standing Order Regarding Hatch- Waxman Cases in Which Infringement is Alleged filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 08/31/2023) (2)
Aug 16, 2023 13 STIPULATION TO EXTEND TIME for Defendants to Answer, Move or Otherwise Respond to Complaint to August 31, 2023 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 08/16/2023) (2)
Aug 16, 2023 N/A SO ORDERED, re 13 STIPULATION TO EXTEND TIME for Defendants to Answer, Move or Otherwise Respond to Complaint to August 31, 2023, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. Reset Answer Deadlines: Aurobindo Pharma Limited answer due 8/31/2023; Aurobindo Pharma USA, Inc. answer due 8/31/2023. Ordered by Judge Colm F. Connolly on 8/16/2023. (kmd) (Entered: 08/16/2023) (0)
Jul 25, 2023 10 NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Myer, R.) (Entered: 07/25/2023) (1)
Jul 25, 2023 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 07/25/2023) (2)
Jul 25, 2023 12 STIPULATION TO EXTEND TIME for Defendants to Answer, Move or Otherwise Respond to Complaint to August 18, 2023 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 07/25/2023) (2)
Jul 25, 2023 N/A SO ORDERED, re 12 STIPULATION TO EXTEND TIME for Defendants to Answer, Move or Otherwise Respond to Complaint to August 18, 2023, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. Reset Answer Deadlines: Aurobindo Pharma Limited answer due 8/18/2023; Aurobindo Pharma USA, Inc. answer due 8/18/2023. Ordered by Judge Colm F. Connolly on 7/25/2023. (kmd) (Entered: 07/25/2023) (0)
Jul 6, 2023 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Aurobindo Pharma Limited on July 5, 2023, filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 07/06/2023) (10)
Jul 6, 2023 9 STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:23-cv-00717-CFC, 1:23-cv-00718-CFC(nmf) (Entered: 07/06/2023) (2)
Jul 5, 2023 7 SUMMONS Returned Executed by Pfizer Inc., PBG Puerto Rico LLC, PF PRISM C.V., C.P. Pharmaceuticals International C.V., PF PRISM IMB B.V..Aurobindo Pharma USA, Inc. served on 7/5/2023, answer due 7/26/2023. (Dellinger, Megan) (Entered: 07/05/2023) (2)
Jul 5, 2023 N/A Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:23-cv-00717-CFC, 1:23-cv-00718-CFC (rjb) (Entered: 07/05/2023) (0)
Jun 30, 2023 1 Complaint* (1)
Jun 30, 2023 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 07/03/2023) (3)
Jun 30, 2023 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/18/2023. Date of Expiration of Patent: 12/8/2025.Thirty Month Stay Deadline: 11/18/2025. (mpb) (Entered: 07/03/2023) (1)
Jun 30, 2023 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (mpb) (Entered: 07/03/2023) (1)
Jun 30, 2023 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (mpb) (Entered: 07/03/2023) (1)
Jun 30, 2023 6 Summons Issued as to Aurobindo Pharma Limited on 6/30/2023; Aurobindo Pharma USA, Inc. on 6/30/2023. (Attachments: # 1 Summons Issued)(mpb) (Entered: 07/03/2023) (0)
Menu